[Ordinary shares, par value $0.0001 per share 64110W102 (**) December 31, 2013 [X] Rule 13d-1(b) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover]
[Joint Filing Agreement Yongqiang Qian Yongqiang Qian Fame Gain Investments Limited Yongqiang Qian Director EX-99.1 2 a14-5098_3ex99d1.htm EX-99.1] [CUSIP No. 477374 102 1. Names of Reporting Persons]
[1 CUSIP No 98426T106 1. NAME OF REPORTING PERSONS]
[SCHEDULE 13D/A (Amendment No. 6) SouFun Holdings Limited (Name of Issuer) Class A ordinary shares, par value HK$1.00 per share (Title of Class of Securities) 836034108** (CUSIP Number) Amit Gupta 6th Floor, Tower A 1 CyberCity, Ebene, Mauritius +230 (403) 6074 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) With a copy to: Thomas J.]
[Oberweis Asset Management, Inc. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) Not Applicable (a) o (b) o 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Illinois NUMBER OF 5 SOLE VOTING POWER None SHARES BENEFICIALLY OWNED BY 6 SHARED VOTING POWER 1,259,344 ADSs* EACH REPORTING PERSON 7 SOLE DISPOSITIVE POWER None WITH]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 174,894,000 Item 6: 0 Item 7: 178,724,000 Item 8: 0 Item 9: 178,724,000 Item 11: 12.487% Item 12: HC Cusip #Y2930P108 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 178,724,000 Item 8: 0 Item 9: 178,724,000 Item 11: 12.487%]
[SECOND AMENDED AND RESTATED JOINT FILING AGREEMENT FROST GAMMA INVESTMENTS TRUST Phillip Frost, M.D. Sole Trustee Phillip Frost, M.D., individually EX-99.8 2 d680214dex998.htm EX-99.8] [CUSIP No. G88685105 2 7 Page 1. NAMES OF REPORTING PERSONS Phillip Frost, M.D. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) x ¨ (a) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) N/A 5. ¨ 6. CITIZENSHIP OR PLACE OF ORGANIZATION]
[JOINT FILING AGREEMENT --------------------------------- Dated: February 14, 2014 Dated: February 14, 2014 WP X ASIA ONLINE INVESTMENT HOLDINGS LIMITED WARBURG PINCUS PRIVATE EQUITY X, L.P. Warburg Pincus X, L.P., its general partner Warburg Pincus X LLC, its general partner Warburg Pincus Partners LLC, its sole member Warburg Pincus & Co., its managing member] [SCHEDULE 13G 58.com Inc. (Name of Issuer) Class A Ordinary Shares, par value US$0.00001 per share (Title of Class of Securities) 31680Q104† (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject]
[SCHEDULE 13G CUSIP No. 43289P106 2 9 Page]
[FORM 10-Q (Mark One) x For the quarterly period ended December 31, 2013 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2013 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2013 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q1213ex32i_tianyinphar.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q1213ex32ii_tianyinphar.htm CERTIFICATION]
